Thymosin alpha 1
胸腺肽α1
Report date: 2024/04/11 17:59:37
Base Information
Drug NameThymosin alpha 1
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSun Yat-Sen University
Inactive CompaniesBeijing Sl Pharmaceutical Co Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A